希玛眼科进一步增持爱康健股份，加强深圳以至大湾区口腔科布局

Xima Ophthalmology (3309.HK) is pleased to announce that it signed an equity transfer agreement with Shenzhen Innovation Investment Group Co., Ltd. (“Shenzhen Venture Capital”) on November 24 to once again increase its holdings and acquire 7% of its shares from Shenzhen Venture Capital at a total price of RMB 45.5 million. After the transaction was completed, the founders of Xima Ophthalmology and iHealth and their core teams held 61.5% and 38.5% of iKangjian Group's holding shares, respectively.

On September 3, 2021, Hima Ophthalmology acquired 55% of iKangjian Dental's holding shares for RMB 385 million (approximately HK$465 million). This increase in iKangjian Group's controlling shareholding will further simplify the shareholder structure, enhance the stability of the shareholding structure, and demonstrate confidence in the future development of iKangjian. Hima expects iHealth's trade fair to be completed in January 2022.

According to information, Hong Kong and the mainland will hold a second meeting on customs clearance in Shenzhen on November 25 to further discuss the details of customs clearance between the two places. Based on iHealth's past performance, it is expected that after customs clearance, its operations will quickly return to normal. At the same time, with the support of Xima Ophthalmology, iHealth will more accurately capture Shenzhen's strong demand for high-quality dental care services. Cima is expected to be a direct beneficiary of iHealth Group's increased valuation and profit growth by strengthening the deployment of dental opportunities after customs clearance.

Since its establishment, Xima Ophthalmology has strived to spread Hong Kong's high-quality medical services to the mainland and create a successful model for medical cooperation between the Mainland and Hong Kong. With ophthalmology services as the core, the company has developed into a multi-specialty Hong Kong-style high-quality specialist medical platform: including stomatology, oncology, and OK mirror businesses, with the goal of establishing leading high-quality Hong Kong-style specialist medical services in the Greater Bay Area and Asia.

As the per capita disposable income of urban residents increases, the nation's awareness of oral health care has awakened, and spending capacity in “improved medical care” fields such as dentistry has also increased markedly. The company's confidence in speeding up the dental department layout in Shenzhen and the Greater Bay Area comes from this.

iHealth Group operates a well-known dental chain in Shenzhen, serving and attracting a large number of cross-border patients from Hong Kong, China. It has excelled in brand management, quality of dental services and financial performance. Some investors said that the mainland dental market, which has huge potential, may begin a new journey in the future medical layout of Xima Ophthalmology. As a powerful ophthalmologist from Hong Kong, Xima Ophthalmology has grasped the “ophthalmology+dental” health trend in the medical service sector, continuously improving the scale and service efficiency of the market service through shared resources and customer groups, and is becoming the core competitive advantage for the company's future development.